Astrana Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Astrana Health generated cash of $68,227,000, which is less than the previous year. Cash used in financing activities reached the amount of $3,421,000 last year. Net change in cash is therefore $6,125,000.
Cash Flow
| 2016 | -1.83M | -247.10K | 6.34M |
|---|---|---|---|
| 2017 | 53.07M | 6.73M | -14.97M |
| 2019 | 13.91M | -180.84M | 163.30M |
| 2020 | 46.16M | 95.49M | -51.69M |
| 2021 | 70.33M | 16.54M | -47.74M |
| 2022 | 82.12M | -7.11M | -20.08M |
| 2023 | 68.22M | -65.52M | 3.42M |
ASTH Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 288.02M | 233.09M | 193.97M | 104.01M | 106.89M | 9.27M | 5.01M |
Operating activities | |||||||
Net income | 57.84M | 45.74M | 46.05M | 122.08M | 14.11M | 25.80M | -9.34M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 17.74M | 17.54M | 17.51M | 18.35M | 18.28M | 19.07M | 351.39K |
Stock-based compensation expense | 22.04M | 16.10M | 6.74M | 3.38M | 0 | 0 | 0 |
| Deferred income tax benefit | 22.04M | 16.10M | 6.74M | 3.38M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | -20.56M | -33.96M | -21.63M | 3.01M | -5.80M | 10.70M | 272.40K |
Inventories | 12.15M | 27.61M | -2.10M | -7.71M | 0 | 0 | 0 |
Accounts payable | -498K | -2.51M | 4.10M | 15.81M | -4.88M | -1.80M | 1.02M |
Cash generated by operating activities | 68.22M | 82.12M | 70.33M | 46.16M | 13.91M | 53.07M | -1.83M |
Investing activities | |||||||
Purchases Of Investments | -6.15M | -1.85M | -28M | -1.79M | -119.00M | -18.00M | 0 |
Investments In Property Plant And Equipment | -28.52M | -22.94M | -19.22M | -1.16M | -1.04M | -2.08M | -262.10K |
Acquisitions Net | -7.53M | -18.45M | -3.90M | 31.42M | -49.37M | 0 | 15K |
Cash generated by investing activities | -65.52M | -7.11M | 16.54M | 95.49M | -180.84M | 6.73M | -247.10K |
Financing activities | |||||||
Common Stock Issued | 0 | 0 | 40.13M | 10.80M | 755K | 2.16M | 200K |
Payments for dividends | -62.07M | -14.03M | -31.08M | -51.31M | -61.71M | -10.44M | 0 |
Repurchases of common stock | -10.19M | -9.25M | -5.73M | -537K | -7.57M | -3.17M | 0 |
Repayments of term debt | 79.17M | -828K | -238.53M | -9.60M | 234.48M | 4.89M | -7.90M |
Cash used in financing activities | 3.42M | -20.08M | -47.74M | -51.69M | 163.30M | -14.97M | 6.34M |
Net Change In Cash | 6.12M | 54.93M | 39.12M | 89.96M | -3.62M | 110.50M | 4.25M |
Cash at end of period | 294.15M | 288.02M | 233.09M | 193.97M | 103.26M | 119.77M | 9.27M |